chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This person experienced heightened MS symptoms including increased impaired mobility in bilateral lower extremities, increased anxiety/stress, and a pounding headache.
severe joint pain in right elbow and left shoulder; severe joint pain in right elbow and left shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Apr2021 (Lot number: FW017s) at the age of 57 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "covid" (unspecified if ongoing). Concomitant medication(s) included: TELMISARTAN; ATORVASTATIN. Vaccination history included: Bnt162b2 (Dose number: 1, Lot number: ER873y, Administration time: 12:00, Vaccine location: Right arm), administration date: 02Apr2021, when the patient was 57 years old, for Covid-19 Immunization. The following information was reported: ARTHRALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 29Apr2021, outcome "not recovered" and all described as "severe joint pain in right elbow and left shoulder". The event "severe joint pain in right elbow and left shoulder" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of arthralgia, arthralgia.   Additional information: The patient did not get COVID tested post vaccination. The patient had no known allergies. The patient did not receive treatment for adverse event. The patient experienced covid prior vaccination.   Follow-up attempts are completed. No further information is expected.
first dose on 06/17/2021, not received second; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 17th June 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 17-Jun-2022 Reporter's comments: Healthcare provider reported that the patient received Shingrix and had not received their second dose. The reporter did not consent to follow-up. The healthcare professional did not provide any adverse event details. Additional Supportive Information: Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Fever of 101.3, Body/joints aches, Hives on arm where shot was given lasted 2 1/2 days, could not raise arm above shoulder.
PATIENT EXPERIENCING HEART RACING 5 MINUTES AFTER RECEIVING THE VACCINE. HIS BLOOD PRESSURE AND HEART RATE WERE HIGH. EMT TOOK HIM IN AMBULANCE AND DID SOME TESTS, HIS HEART WAS FINE AND THEY SENT HIM HOME AFTER HIS SYMPTOMS RESOLVED.  OVERALL, IT COULD HAVE BEEN ANXIETY RELATED.
Caller stated that 5 mins after receiving shot she felt her neck stiffing closed to spinal cord. Drove home and that when the body ache started, fever, chest pain. Painful on the right side that she could not stand to touch the skin surface. Skin was very sensitive like a nerve.
Information has been received from a healthcare worker (certified medical Assistant (C.M.A)) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 10-FEB-2015, the patient was administered with a dose of improperly stored ZOSTAVAX (lot#, expiration date and dose not provided), subcutaneously. No adverse effects were reported. This one of several reports received from the same source. Additional information has been requested.
taste issues; doesn't eat or sleep well; doesn't eat or sleep well; Chills; muscle ache; low-grade fever; headache; surge of acid in my mouth; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (surge of acid in my mouth), TASTE DISORDER (taste issues), FEEDING DISORDER (doesn't eat or sleep well), INSOMNIA (doesn't eat or sleep well) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (surge of acid in my mouth). On an unknown date, the patient experienced TASTE DISORDER (taste issues), FEEDING DISORDER (doesn't eat or sleep well), INSOMNIA (doesn't eat or sleep well), CHILLS (Chills), MYALGIA (muscle ache), PYREXIA (low-grade fever) and HEADACHE (headache). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (surge of acid in my mouth), TASTE DISORDER (taste issues), FEEDING DISORDER (doesn't eat or sleep well), INSOMNIA (doesn't eat or sleep well), CHILLS (Chills), MYALGIA (muscle ache), PYREXIA (low-grade fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided. No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-109904 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109904:Husband case
Patient presents to the emergency department with a complaint of generalized illness.  Patient states she received her second dosage of Covid vaccine on January 20 she states that she started to have the symptoms on January 23 and they are worse today that being January 24.  She comes now because of recurrent vomiting headaches body aches occasional cough overall malaise and fatigue.  She has no other acute symptomatology comes in now for further care.  Patient is written for Zofran given initial dosage here and sent with a prescription.  She will drink plenty of fluids contact workplace health in regards to her restrictions and returning to work.  Patient felt better on 1/25/21
pt recvd flu vax & devel wheezing, coughing & excess phlegm; sx lasted approx 6 to 7 months, then cleared up;
4x3 inch area at injection site red, swollen, warm. Occurred 1 week after injection. Went to urgent care, diagnosed with cellulitis, antibiotics given.
Itchy; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Oct2021 at 13:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer and known allergies to bee venom. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Oct2021 at 13:15, the patient experienced itchy. The event itchy did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itchy was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
1 dose on 12/20/2005, second on 6/26/2006; 1 dose on 12/20/2005, second on 6/26/2006; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 45-year-old male patient who received HAB (Twinrix) (batch number AHABB019BA, expiry date unknown) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAB (Twinrix) for prophylaxis and hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (1st dose received on 20th December 2005, Lot Number AHABB019BA).   On 26th June 2006, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, the patient received the 3rd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 26th June 2006, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device and not applicable after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the drug dose administration interval too long and incomplete course of vaccination were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for 3rd dose. The pharmacist called and asked about a patient who received the first 2 doses of Twinrix over 15 years from the day of reporting. The pharmacist stated that the patient received the second dose later than the recommended interval (Schedule of 3 doses at 0, 1, and 6 months), which led to lengthening of vaccination schedule. Till the time of reporting the patient had not received their 3rd dose, which led to incomplete course of vaccination. The reporter consented to follow up.
Ringing in left ear that has progressively increased in volume for the past four days, now it feels like the ringing is louder than other sounds. I feel like the ringing may be causing a headache similar to an extremely loud noise exposure. I'm also becoming very sensitive to any noise, enough to file this report.
I woke  up in the middle of the night with a terrible headache and body aches and chills.  The next day these symptoms continued and I also had a fever (100.3).  My lower back hurt so much that I felt as if I had fallen down a long flight of stairs.  I had to take 1/2 day off of work and spend the remainder of the day in bed.  Eventually I took 2 extra strength Tylenol which helped alleviate my symptoms.  The next morning  I woke up feeling totally fine.
I had my vaccination on 09/13/2022. On 03/19/2023 I developed double vision and numbness on the right side of my face. I called my ophthalmologist and I asked if had to do with the glaucoma. They referred me to urgent care to make sure. I had a CAT Scan I had a large occlusion in the left vertebral arteries I then had to have an MRI in which I was transferred to another hospital. It was determined that the vertebral artery occlusion had been there for a long duration. I don't have a neurology appointment until June. The double vision has subsided. I am having surgery on the right eye of laser incision to create a drainage so there won't be a buildup of fluid.
High Fever 102 non responsive to Tylenol and persistent vomiting requiring overnight hospitalization.
BURNING AND TINGLING ON HER UPPER AND POSTERIOR SHOULDERS, 1 HOUR AFTER VACCINES. REPORTED AT 1358 REC'D BENADRYL CAPSULES P.O.
Day following vaccine mother called stating client at home experiencing illness with nausea, vomiting, fever. Unsure of what temperature is has not taken antipyretic medication due to vomiting. Highest temp 102 degrees. No doctor visit. Recovered after 3 days. No other family/friends reported illness.
states administered H1N1 vaccine 2-10-10 then by Friday 2-12-10 "began to feel badly c/o fever, congestion, headache, body aches, and nausea. Stated no fever today - 2-18-10. However, still feels dull H/A and body aches. Noted took OTC cold medicine. As of 2-18-10 still dull H/A, body aches, some congestion.
About a month later after the 2nd dose vaccine, I developed a shingles infection on 3/2/2021. I had pain and discomfort across my chest and back. Then I started getting spots under the right breast. I went to the doctor and was prescribed valacyclovir. I have not been vaccinated for shingles at time. It took about a month for the shingles rash to resolve. I had another event on July 23, 2021. I had a bladder infection. I previous had a bladder infection on 1/11/2021 after the 1st dose of the Moderna vaccine. I have never had a bladder infection before. I felt pressure and urgency. I did go see my doctor and was prescribed antibiotics which cleared it up right away.
Patient received a 3rd dose of Moderna. 1st dose on 12/30/20, 2nd dose on 2/8/21, 3rd dose on 4/23/21.
Fever - temp of 99.4 started about 24 hours after vaccination and lasted about 36 hours.  Took ibuprofen. Fatigue - same as above.  Rested.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies and past drug reactions/allergies were not reported. On an unknown date in 2013, the patient was vaccinated with the first dose of GARDASIL (strength, route, anatomical location, lot # and expiration date were not reported) for prophylaxis; then, on 09-FEB-2017, the patient was vaccinated with the second dose of GARDASIL (strength, route, anatomical location, lot # and expiration date were not reported) for prophylaxis; and finally, on 10-MAR-2017, the patient was vaccinated with the third dose of GARDASIL 9 (strength, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. No adverse effects were reported.
pt recvd vax; 24-30 hrs later exp welts on trunk which were 1 inch in diam & itching; additionally felt feverish & had hot & cold flashes;
Initial report received on 11/Aug/2006 from a health care professional.  AN 18-year-old male patient with no current illness had received a subcutaneous dose of Menactra, lot number U2138AA, in the left deltoid, on 02/Aug/2006.  A subcutaneous injection of Menactra is not a recommended route of administration by the manufacturer.  Three days post-immunization, the patient experiences nausea, headache, stomach pains, cramping, and diarrhea.  The patient was seen in the emergency room three days later and was given fluids.  A stool culture was performed, but the results were not reported.  The patient was subsequently discharged from the emergency room with instructions to go home and rest.  The recovery status of the patient was reported as not recovered.
Dizziness Lethargic Narrative: Missed 2 days off work due to these side effects
Patient complained  of pain  from injection site of right shoulder extending  to right next and upper right chest. Pain would not go away while waiting in pharmacy. 911 was called, came, picked up patient in  30 minutes.
Circumscribed edema at both sides right anterior thighs with mild erythema right, slightly warm to touch right, without tenderness, induration.
Swelling & redness (warmth) from the injection site down to the elbow plus soreness.
Flu shot on the left hand and swelling in the thoracic area on both left and right. Axillary edema on the right side that doesn't go away even after 45 days. Severe shoulder blade pain, and back pain. swollen intramammary lymph node
Day 13 after VARIVAX given; she developed 5 days of fever 103-102 with vesicles-papules (more than 50 lesions) arms - legs - buttocks - face "is chickenpox".
36-48 hours post administration-red, warm swollen lump under injection site for ZOSTAVAX.
5 min after shot I had instant tachycardia and short of breathe, I become diaphoretic and felt like I was going to have a syncoable  episode . Last 10 minutes or so. Later on at 830 pm I felt the shaky syncopable feeling and unwell feeling. Like I was going to barf.
Fever Started on Friday am, disapated by Saturday am. Child awoke with small red area on Saturday. By Saturday night patient went to ER with a 19 cm long x 5 cm wide area of cellulitis. Treated with Amoxil 600IM then given Keflex 500 QID and will reduce to TID. Seen 09/12/2005 in office still having area of redness.
Following the vaccination, the pt developed severe pain in his shoulder and neck which lasted 2-3 days.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the vaccines were stored in freezer and required vials were taken out to place in fridge as needed. No concomitant medications were provided by the reporter. No treatment given to patients.
The injection was on the right arm, developed a rash on the armpit of the right arm the next day. It took a week for the rash to go away. There was pain in the armpit when the rash was present. A heating pad or hot showers made the rash and pain worse. Also had experienced a low-grade fever, mild headache, body aches, dizziness, and fatigue.
From telephone contact on 11/19/02, it was reported that a 48 year old female received Fluzone (lot number U0929AA) at a pharmacy on 10/22/02. The patient had immediate pain at injection site along with a large bruise. The patient was seen by her primary care doctor on 11/15/02 and was diagnosed with Tendonitis and bursitis.
Received ZOSTAVAX vaccine on 3-30-15. Developed site rash on 4-1-15, came to pharmacy on 4-3-15 with large red rash with blisters and a skin tear. Doctor monitoring for cellulitis due to being reddish-purple surrounding rash-told to cover rash.
32 year old male received expired Adacel; Initial information received on 06-May-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to case 2019SA126028 (same reporter).  This case involves a 32 years old male patient who received an expired vaccine (first dose) DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (lot U5656AA or U6565AA) via intramuscular route in the left arm, on 05-May-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication reported as none.  It was a case of actual medication error due to expired vaccine used.  It was unknown whether the patient had any adverse reactions.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.
Patient experienced syncope within 8 minutes of receiving vaccine. Fainted and hit her head on the floor. Regained consciousness within 10 seconds of falling. Patient receives vaccine every year.
Hives about 1 hr after the following vaccines: MMR, VZV, IPV, DTAP, Flu 1/19/11 was seen by RN given BENADRYL - hives subsided. Developed fever to 102 degrees F same night.
Twelve hours post injection: fever, aches, chills, arm pain. 36 hours post injection: lymph node swelling, redness, left arm tingling, edema
Starting on 06/17/2021 I had chills and very intense body aches, which went away the next morning.  However, when I woke up on 06/18/2021 I had decently swollen lymph nodes the size of olives on the left side of where my neck meets my trapezoid muscle.  I also had physically noticeable swollen lymph nodes under my left arm.  Both swollen areas are painful and tender.
Patient reports not feeling well (sore arm, general malaise) beginning day after the vaccination and worsening for two weeks until she developed "canker sore or ulcer-like blisters" on the right inside of her mouth and throat. Her tongue was also swollen (she claims to roughly twice normal size) on the right side and was bright red. She also complained of dysphagia and difficulty eating. She went into the clinic on 8/2/19 and was diagnosed with "Zoster with other complications" per diagnosis code and was prescribed Magic mouthwash 1:1:1 suspension to be used BID x7d and valacyclovir 1 gram TID x7d and seems to be feeling better when I spoke with her afternoon of 8/8/19.
While driving home in traffic from getting the vaccine, I felt a tingling over my whole body and then everything started to spin (vertigo). This lasted for about 10 seconds of severe vertigo and then stopped. I thought that was weird and kept driving (was in stop and go traffic) then about 1 minute later it started again and thankfully I was stopped at the time in traffic. I leaned my  seat back slightly and called my wife to tell her where I am. I couldn't pull over because there was a cement barrier on one side and 4 lanes of traffic on the other. I kept on the phone with her for the remained of my drive and it occurred one more time when I was driving home. Once home, a couple more times I felt it coming on but it didn't ever happen again. I took my blood pressure and it was normal, boarderline high when I got home (140/84). The next morning I had a fever and severe muscle aches and body aches which lasted most of the day and then today I've felt totally fine (today being 1/23).
Patient is 11 yrs old and received Pfizer COVID 19 for 12 yr old and up.
REported dizziness while sitting in observation . Brought to medical screening to lay down . Anxiety related to shots. Left in stable condition at 11:12 A.M. Recorded by Medic
Since May 2021, approx. 5 weeks after vaccination I get rashes on various parts of my body (1st time left face and neck area, 2nd time identical, symmetrical rashes on both left and right upper thigh, 3rd and most recent on the right arm inner bicep area.  Rashes usually persist about 10 days then disappear.  Red, raised in appearance with very minor itching.
MOM STATED DOB 5/1/2010 ON CONSENT FORM AND VERIFIED SO PATIENT RECEIVED PFIZER GRAY CAP VIAL DOSE 0.3  ON 5/24/22. INSURANCE REJECTED 2ND DOSE 6/21/22 DUE TO INVALID DOB. ACTUAL DOB 5/1/2011 (11YRS) . MOM VERFIED SHE PROVIDED INCURRENT DOB ON CONSENT FORM ON 1ST DOSE AND ALSO ON 2ND DOSE CONSENT FORM.
Sore arm with tender big hard ball lump at site of injection. Also tingling & burning in my back shoulder blade area to back of upper arm randomly.
Felt tightening of chest cavity along with warm ?flush? feeling. After a few minutes left side felt less pressure but pressure persisted in right chest area with pain radiating from right arm to back (behind shoulder blade). The right back pain persisted for multiple days. Sought Urgent Care help after a few days. Was prescribed muscle relaxant and pain relief gel, and advised to continue using inhalers.
At 12:43 PM, pt began complaining of "thick tongue" feeling as well as numb lips and rash. No urticaria observed. Pt requested BENADRYL due to her numerous allergy history and stated these symptoms were the same as previous reaction symptoms. Pt stated symptoms resolved at 13:03, 10 minutes after BENADRYL.